This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Vanessa G. Schweitzer, MD; Nels R. Olson, MD

Arch Otolaryngol. 1984;110(4):258-260.

Abstract
• Thirty-two cases of sudden, symmetrical, high-frequency, sensorineural hearing loss associated with intravenous (IV) and oral erythromycin therapy have been published since 1973. We treated a patient with reversible ototoxicity associated with IV erythromycin for the treatment of legionnaire's disease.

(Arch Otolaryngol 1984;110:258-260)

Author Affiliations
From the Department of Otorhinolaryngology—Head and Neck Surgery, University of Michigan (Dr Schweitzer), and the Department of Otorhinolaryngology—Head and Neck Surgery, St Joseph-Mercy Hospital and the Department of Otorhinolaryngology—Head and Neck Surgery, University of Michigan Hospital (Dr Olson), Ann Arbor. Dr Schweitzer is now with Henry Ford Hospital, Detroit.

Footnotes
Accepted for publication April 22, 1983.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hearing Loss
Nadol
NEJM 1993;329:1092-1102.
FULL TEXT  

Erythromycin Ototoxicity and Acute Psychotic Reaction in Cancer Patients With Hepatic Dysfunction
Umstead and Neumann
Arch Intern Med 1986;146:897-899.
ABSTRACT